(Q45743964)

15 December 2017

title

Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice (English)

1 reference

15 December 2017

1 reference

1 reference

Burger RA

1

1 reference

15 December 2017

Billingsley JL

2

1 reference

15 December 2017

Huffman JH

3

1 reference

15 December 2017

Bailey KW

4

1 reference

15 December 2017

Kim CU

5

1 reference

15 December 2017

Sidwell RW

6

1 reference

15 December 2017

publication date

1 April 2000

1 reference

15 December 2017

published in

Immunopharmacology

1 reference

15 December 2017

volume

47

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

45-52

1 reference

15 December 2017

Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

The molecular biology of influenza virus pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

The immunology of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Effect of selenazofurin on influenza A and B virus infections of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900184-8

7 January 2021

10.1016/S0162-3109(99)00184-8

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017